SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.

Rio-Machin, A; Vulliamy, T; Hug, N; Walne, A; Tawana, K; Cardoso, S; Ellison, A; Pontikos, N; Wang, J; Tummala, H; et al. Rio-Machin, A; Vulliamy, T; Hug, N; Walne, A; Tawana, K; Cardoso, S; Ellison, A; Pontikos, N; Wang, J; Tummala, H; Al Seraihi, AFH; Alnajar, J; Bewicke-Copley, F; Armes, H; Barnett, M; Bloor, A; Bödör, C; Bowen, D; Fenaux, P; Green, A; Hallahan, A; Hjorth-Hansen, H; Hossain, U; Killick, S; Lawson, S; Layton, M; Male, AM; Marsh, J; Mehta, P; Mous, R; Nomdedéu, JF; Owen, C; Pavlu, J; Payne, EM; Protheroe, RE; Preudhomme, C; Pujol-Moix, N; Renneville, A; Russell, N; Saggar, A; Sciuccati, G; Taussig, D; Toze, CL; Uyttebroeck, A; Vandenberghe, P; Schlegelberger, B; Ripperger, T; Steinemann, D; Wu, J; Mason, J; Page, P; Akiki, S; Reay, K; Cavenagh, JD; Plagnol, V; Caceres, JF; Fitzgibbon, J; Dokal, I (2020) The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants. Nat Commun, 11 (1). p. 1044. ISSN 2041-1723 https://doi.org/10.1038/s41467-020-14829-5
SGUL Authors: Saggar, Anand Kumar

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. Here we report a cohort of 86 acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) families with 49 harboring germline variants in 16 previously defined loci (57%). Whole exome sequencing in a further 37 uncharacterized families (43%) allowed us to rationalize 65 new candidate loci, including genes mutated in rare hematological syndromes (ADA, GP6, IL17RA, PRF1 and SEC23B), reported in prior MDS/AML or inherited bone marrow failure series (DNAH9, NAPRT1 and SH2B3) or variants at novel loci (DHX34) that appear specific to inherited forms of myeloid malignancies. Altogether, our series of MDS/AML families offer novel insights into the etiology of myeloid malignancies and provide a framework to prioritize variants for inclusion into routine diagnostics and patient management.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing,adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visithttp://creativecommons.org/licenses/by/4.0/. © The Author(s) 2020
Keywords: Adaptor Proteins, Signal Transducing, Adenosine Deaminase, Axonemal Dyneins, Cohort Studies, Germ-Line Mutation, Humans, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Nonsense Mediated mRNA Decay, Pedigree, Perforin, Platelet Membrane Glycoproteins, RNA Helicases, Receptors, Interleukin-17, Vesicular Transport Proteins, Whole Exome Sequencing, Humans, Myelodysplastic Syndromes, Adenosine Deaminase, RNA Helicases, Adaptor Proteins, Signal Transducing, Platelet Membrane Glycoproteins, Vesicular Transport Proteins, Cohort Studies, Pedigree, Germ-Line Mutation, Receptors, Interleukin-17, Leukemia, Myeloid, Acute, Perforin, Axonemal Dyneins, Nonsense Mediated mRNA Decay, Whole Exome Sequencing, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Biomedical Education (INMEBE)
Journal or Publication Title: Nat Commun
ISSN: 2041-1723
Language: eng
Dates:
DateEvent
25 February 2020Published
27 January 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MC_UU_00007/7Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/P018440/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
14032BloodwiseUNSPECIFIED
UNSPECIFIEDCancer Research UKhttp://dx.doi.org/10.13039/501100000289
PubMed ID: 32098966
Web of Science ID: WOS:000564284600002
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112494
Publisher's version: https://doi.org/10.1038/s41467-020-14829-5

Actions (login required)

Edit Item Edit Item